Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Nov 15;26(146):170080.
doi: 10.1183/16000617.0080-2017. Print 2017 Dec 31.

Current and new challenges in occupational lung diseases

Affiliations
Review

Current and new challenges in occupational lung diseases

Sara De Matteis et al. Eur Respir Rev. .

Abstract

Occupational lung diseases are an important public health issue and are avoidable through preventive interventions in the workplace. Up-to-date knowledge about changes in exposure to occupational hazards as a result of technological and industrial developments is essential to the design and implementation of efficient and effective workplace preventive measures. New occupational agents with unknown respiratory health effects are constantly introduced to the market and require periodic health surveillance among exposed workers to detect early signs of adverse respiratory effects. In addition, the ageing workforce, many of whom have pre-existing respiratory conditions, poses new challenges in terms of the diagnosis and management of occupational lung diseases. Primary preventive interventions aimed to reduce exposure levels in the workplace remain pivotal for elimination of the occupational lung disease burden. To achieve this goal there is still a clear need for setting standard occupational exposure limits based on transparent evidence-based methodology, in particular for carcinogens and sensitising agents that expose large working populations to risk. The present overview, focused on the occupational lung disease burden in Europe, proposes directions for all parties involved in the prevention of occupational lung disease, from researchers and occupational and respiratory health professionals to workers and employers.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

FIGURE 1
FIGURE 1
Estimated annual changes in incidence of occupational asthma in Europe based on national reporting surveillance data. RNV3P: Le Réseau national de vigilance et de prévention des pathologies professionnelles; MCP: Programme de surveillance des maladies à caractère professionnel (French surveillance system); MALPROF: Malattie Professionali (Italian surveillance system). Reproduced and modified from [4] with permission.
FIGURE 2
FIGURE 2
Mesothelioma and related asbestos-related lung cancer mortality by country, 1979–2012. Reproduced and modified from [11] with permission.
FIGURE 3
FIGURE 3
Number of cancer cases from cancer registrations attributable to the most prevalent occupational carcinogens in the UK in 2004. 85% of the cancer cases were attributable to the top 10 chemical agents. PAHs: polycyclic aromatic hydrocarbons; ETS: environmental tobacco smoke. Reproduced and modified from [11] with permission.

Similar articles

Cited by

References

    1. Siracusa A, De Blay F, Folletti I, et al. Asthma and exposure to cleaning products – a European Academy of Allergy and Clinical Immunology task force consensus statement. Allergy 2013; 68: 1532–1545. - PubMed
    1. Meredith SK, Taylor VM, McDonald JC. Occupational respiratory disease in the United Kingdom 1989: a report to the British Thoracic Society and the Society of Occupational Medicine by the SWORD project group. Br J Ind Med 1991; 48: 292–298. - PMC - PubMed
    1. Meyer JD, Holt DL, Chen Y, et al. SWORD '99: surveillance of work-related and occupational respiratory disease in the UK. Occup Med 2001; 51: 204–208. - PubMed
    1. Stocks SJ, McNamee R, van der Molen HF, et al. Trends in incidence of occupational asthma, contact dermatitis, noise-induced hearing loss, carpal tunnel syndrome and upper limb musculoskeletal disorders in European countries from 2000 to 2012. Occup Environ Med 2015; 72: 294–303. - PubMed
    1. Vandenplas O, Wiszniewska M, Raulf M, et al. EAACI position paper: irritant-induced asthma. Allergy 2014; 69: 1141–1153. - PubMed

MeSH terms

Substances